Keller to oversee shared resources at Rogel Cancer Center

Media contact: Nicole Fawcett, 734-764-2220 |  Patients may contact Cancer AnswerLine 800-865-1125

ANN ARBOR, Michigan — The University of Michigan Rogel Cancer Center has named Evan T. Keller, D.V.M., Ph.D., associate director for shared resources.

Keller is professor of urology and pathology at Michigan Medicine. He currently co-leads the Rogel Cancer Center’s single cell analysis shared resource.

In his new role, Keller will provide strategic oversight and direction for the center’s 11 shared resources, which provide access to scientific consultation, services and technologies that enhance scientific interaction and productivity.

“Dr. Keller has demonstrated leadership and commitment to the Rogel Cancer Center over many years. I am confident his expertise will enable our shared resources to play an integral role in helping our center’s members pursue cutting edge research,” says Eric Fearon, M.D., Ph.D., director of the Rogel Cancer Center.

Keller earned a doctor of veterinary medicine and master’s of preventive veterinary medicine from the University of California Davis and a doctorate in developmental biology from the University of Wisconsin.

His research focuses on the biology of cancer metastasis, chemoresistance and single cell analysis methodology. He directs a multi-million dollar NIH-funded program project award on prostate cancer metastasis to bone. Using a combination of molecular, cellular and animal studies as well clinical trials, his lab explores genes that regulate metastasis and the interaction between the host microenvironment and cancer cells. He is using single cell RNA-Seq to identify rare cell populations and promote precision medicine.

“I look forward to enhancing the impact of shared resources on the Rogel Cancer Center’s research and educational missions, expanding on the excellent foundation that exists to identify new opportunities for members to access shared resources in their work,” Keller says.

Keller replaces Alnawaz Rehemtulla, Ph.D., who stepped down earlier this year to focus on his laboratory research program. Keller’s appointment is effective Sept. 1.